SEC Form 4 · accession 0001179110-17-015154
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Dec 6, 2017
Accepted (ET)
Dec 8, 2017 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Dec 6, 2017 | M | 530,000 | $26.6973 | A | 3,677,913 | D | |
| Common shares without par value | Dec 6, 2017 | S | 600 | $54.325 | D | 3,677,313 | D | |
| Common shares without par value | Dec 6, 2017 | S | 2,800 | $54.33 | D | 3,674,513 | D | |
| Common shares without par value | Dec 6, 2017 | S | 1,000 | $54.34 | D | 3,673,513 | D | |
| Common shares without par value | Dec 6, 2017 | S | 300 | $54.345 | D | 3,673,213 | D | |
| Common shares without par value | Dec 6, 2017 | S | 800 | $54.35 | D | 3,672,413 | D | |
| Common shares without par value | Dec 6, 2017 | S | 2,650 | $54.355 | D | 3,669,763 | D | |
| Common shares without par value | Dec 6, 2017 | S | 7,450 | $54.36 | D | 3,662,313 | D | |
| Common shares without par value | Dec 6, 2017 | S | 2,407 | $54.365 | D | 3,659,906 | D | |
| Common shares without par value | Dec 6, 2017 | S | 8,035 | $54.37 | D | 3,651,871 | D | |
| Common shares without par value | Dec 6, 2017 | S | 5,199 | $54.375 | D | 3,646,672 | D | |
| Common shares without par value | Dec 6, 2017 | S | 16,446 | $54.38 | D | 3,630,226 | D | |
| Common shares without par value | Dec 6, 2017 | S | 8,502 | $54.385 | D | 3,621,724 | D | |
| Common shares without par value | Dec 6, 2017 | S | 27,636 | $54.39 | D | 3,594,088 | D | |
| Common shares without par value | Dec 6, 2017 | S | 5,435 | $54.395 | D | 3,588,653 | D | |
| Common shares without par value | Dec 6, 2017 | S | 100 | $54.3975 | D | 3,588,553 | D | |
| Common shares without par value | Dec 6, 2017 | S | 19,900 | $54.40 | D | 3,568,653 | D | |
| Common shares without par value | Dec 6, 2017 | S | 14,181 | $54.405 | D | 3,554,472 | D | |
| Common shares without par value | Dec 6, 2017 | S | 100 | $54.4075 | D | 3,554,372 | D | |
| Common shares without par value | Dec 6, 2017 | S | 24,651 | $54.41 | D | 3,529,721 | D | |
| Common shares without par value | Dec 6, 2017 | S | 8,167 | $54.415 | D | 3,521,554 | D | |
| Common shares without par value | Dec 6, 2017 | S | 100 | $54.4175 | D | 3,521,454 | D | |
| Common shares without par value | Dec 6, 2017 | S | 39,699 | $54.42 | D | 3,481,755 | D | |
| Common shares without par value | Dec 6, 2017 | S | 21,402 | $54.425 | D | 3,460,353 | D | |
| Common shares without par value | Dec 6, 2017 | S | 19,665 | $54.43 | D | 3,440,688 | D | |
| Common shares without par value | Dec 6, 2017 | S | 10,833 | $54.435 | D | 3,429,855 | D | |
| Common shares without par value | Dec 6, 2017 | S | 9,150 | $54.44 | D | 3,420,705 | D | |
| Common shares without par value | Dec 6, 2017 | S | 3,501 | $54.445 | D | 3,417,204 | D | |
| Common shares without par value | Dec 6, 2017 | S | 13,800 | $54.45 | D | 3,403,404 | D | |
| Common shares without par value | Dec 6, 2017 | S | 2,377 | $54.455 | D | 3,401,027 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $26.6973 | Dec 6, 2017 | M | 530,000 | D | Feb 15, 2011 | Feb 14, 2018 | Common shares | 530,000 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 5.